Bluesight and Medacist provide medication management and drug diversion software platforms for more than 2,000 hospitals in the U.S. Bluesight has raised nearly $50 million, including from the venture capital arms of Oakland, Calif.-based Kaiser Permanente and Raleigh, N.C.-based UNC Health Rex (Rex Health Ventures).
“Technological advancements, including artificial intelligence, are digitizing healthcare and driving demand for software innovations in medication management,” said Bluesight co-founder and CEO Kevin MacDonald, who will lead the combined company, in a July 17 news release. “Health system pharmacies are looking for solutions that lower costs, increase efficiency, and improve compliance.”
Terms of the deal were not disclosed.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
